Stock Events

Stock Events

Tscan Therapeutics (TCRX) Q2 2025 Earnings

6MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.32

-0.3

-0.27

-0.25

Details

Expected EPS

-0.291667

Actual EPS

-0.26

Surprise EPS

0.03

Surprise Percent

+10.86%

Description

Tscan Therapeutics (TCRX) has reported earnings of -0.26 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.